ZTEK - Healthcare Shares Bid Up Following New Distribution And Supply Agreement

2023-08-24 09:20:37 ET

A Canadian %Healthcare company is already stealing the show on Thursday after the company announced that it has signed a distribution and supply agreement with Henry Schein, Inc. According to the release, the initial agreement will be for a period of three years.

This news caused traders to become eager for shares of %Zentek (Nasdaq: ), with traders currently willing to buy shares at $1.46/share (+8.15% implied open for sellers) at the time of writing. This move comes right after shares of this small cap bounced off recently established support.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. It is focused on commercializing %ZENGuard , a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.